
Marco Krengli
Marco Krengli is a prominent Italian radio-oncologist and the director of Radiotherapy at the Istituto Oncologico Veneto. He is also the president of the Associazione Italiana di Radioterapia e Oncologia Clinica (AIRO). Krengli has been an advocate for the importance of radiotherapy in cancer treatment, emphasizing its role in personalized medicine and the need for improved integration within multidisciplinary cancer care teams. His contributions to the field focus on enhancing treatment protocols and expanding access to radiotherapy for patients, particularly in light of the current challenges faced by the healthcare system in Italy.
Not in the pool (under ¢1).
Recent news mentions
Marco Krengli is one of the eight professors who signed the study analyzing university outcomes.
Test di Medicina 2025, lo studio che dimostra che il vecchio «quizzone» non era una lotteria, ma serviva a selezionare i più braviMarco Krengli, president of the Italian Association of Radiotherapy and Clinical Oncology, highlights the importance of modern radiotherapy.
La durata della radioterapia si può dimezzare (mantenendo la stessa efficacia) per i tumori a prostata e senoMarco Krengli is the president of the Italian Association of Radiotherapy and Clinical Oncology (Airo).
Radioterapia decisiva per curare (e guarire) i tumori: serve al 70% dei malati, ma in Italia è poco sfruttataMarco Krengli highlighted the relevance of radiotherapy for oligometastatic patients.
Radioterapia a rischio in Italia: mancano i medici. Ma è indispensabile per 7 malati di tumore su 10
















